Variant report
Variant | nsv559129 |
---|---|
Chromosome Location | chr12:60522829-60540108 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:4)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
(count:4 , 50 per page) page:
1
No. | Distal block | Cell Line | Cell type | Cell Stage |
---|---|---|---|---|
1 | chr12:60539977..60540691-chr18:58172003..58172727,2 | MCF-7 | breast: | |
2 | chr12:60535718..60536628-chr12:60888012..60888523,2 | MCF-7 | breast: | |
3 | chr12:60532105..60534089-chr12:60535432..60537757,2 | K562 | blood: | |
4 | chr12:60532105..60534089-chr12:60535432..60537757,2 | K562 | blood: |
No data |
No data |
No data |
No data |
No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs74098525 | chr12:60522836-60522837 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
2 | rs374221770 | chr12:60522867-60522868 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
3 | rs538336333 | chr12:60522912-60522913 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
4 | rs552029432 | chr12:60522957-60522958 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
5 | rs183524419 | chr12:60523091-60523092 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
6 | rs114134052 | chr12:60523110-60523111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
7 | rs188473221 | chr12:60523155-60523156 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572798413 | chr12:60523277-60523278 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
9 | rs145888594 | chr12:60523296-60523297 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
10 | rs554934054 | chr12:60523316-60523317 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
11 | rs193107520 | chr12:60523348-60523349 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
12 | rs543882340 | chr12:60523371-60523372 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
13 | rs185836102 | chr12:60523423-60523424 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
14 | rs4758852 | chr12:60523439-60523440 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
15 | rs4758853 | chr12:60523462-60523463 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
16 | rs4758854 | chr12:60523480-60523481 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
17 | rs112659781 | chr12:60523484-60523485 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
18 | rs73109768 | chr12:60523499-60523500 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
19 | rs562845498 | chr12:60523512-60523513 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
20 | rs189301161 | chr12:60523520-60523521 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
21 | rs541659153 | chr12:60523552-60523553 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
22 | rs571831849 | chr12:60523569-60523570 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
23 | rs191383186 | chr12:60523573-60523574 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
24 | rs548077767 | chr12:60523581-60523582 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
25 | rs374386690 | chr12:60523600-60523601 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
26 | rs539493592 | chr12:60531011-60531012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs11173336 | chr12:60531030-60531031 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
28 | rs557911625 | chr12:60531045-60531046 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs192732047 | chr12:60531049-60531050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
30 | rs141893064 | chr12:60531123-60531124 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs150633553 | chr12:60531184-60531185 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs73368872 | chr12:60531212-60531213 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs529802359 | chr12:60531223-60531224 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs185046097 | chr12:60531238-60531239 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs139700237 | chr12:60531248-60531249 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs574418357 | chr12:60531259-60531260 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs531813302 | chr12:60531299-60531300 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs551736304 | chr12:60531371-60531372 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs34345852 | chr12:60531396-60531397 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs140728230 | chr12:60531422-60531423 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs571805215 | chr12:60531478-60531479 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs11173337 | chr12:60531507-60531508 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
43 | rs189560691 | chr12:60531522-60531523 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs182093667 | chr12:60531523-60531524 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs535049601 | chr12:60531577-60531578 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs538134874 | chr12:60531621-60531622 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
47 | rs554926226 | chr12:60531649-60531650 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
48 | rs563608736 | chr12:60531665-60531666 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
49 | rs568887940 | chr12:60531682-60531683 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
50 | rs144603412 | chr12:60531689-60531690 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Wilms tumour | 21544195 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Malaria | 21533027 | CNVD |
Chronic lymphocytic leukemia | 22228453 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Chronic lymphocytic leukemia | 21670202 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Autism | 22495311 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Breast cancer | 21949216 | CNVD |
Carcinoma ex pleomorphic adenoma | 18828159 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Cancer | 21637783 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Burkitt''s lymphoma | 18698080 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Gastrointestinal stromal cancer | 20470368 | CNVD |
Adenoid cystic carcinoma | 17372589 | CNVD |
Lissencephaly | 21572526 | CNVD |
Lung cancer | 18438408 | CNVD |
Breast cancer | 19602461 | CNVD |
Breast cancer | 17899364 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Prostate cancer | 18632612 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
liposarcomas | 17372913 | CNVD |
Non-small cell lung cancer | 24170126 | CNVD |
Cancer | 16751803 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Breast cancer | 21785460 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Hodgkin''s lymphoma | 18179710 | CNVD |
Urothelial cell carcinoma | 18451213 | CNVD |
Melanoma | 18172304 | CNVD |
Glioblastoma multiforme | 21390271 | CNVD |
Cancer | 20164919 | CNVD |
Leukemia | 18628472 | CNVD |
Glioblastoma multiforme | 22291905 | CNVD |
Glioblastoma multiforme | 19435819 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Phyllodes tumor | 17334353 | CNVD |
Glaucoma | 21310917 | CNVD |
Breast cancer | 16272173 | CNVD |
Mental retardation | 19951919 | CNVD |
Glaucoma | 21447600 | CNVD |
Non-syndromic sensorineural hearing loss | 15273396 | CNVD |
Developmental delay | 21267005 | CNVD |
12q14 microdeletion syndrome | 21267005 | CNVD |
Developmental delay | 19277063 | CNVD |
Dwarfism | 19277063 | CNVD |
Fibroblasts | 20926602 | CNVD |
Follicular lymphoma | 18703704 | CNVD |
Acute myeloid leukemia | 21251322 | CNVD |
Glioblastoma multiforme | 20080666 | CNVD |
Medulloblastoma | 19270706 | CNVD |
Breast cancer | 17133270 | CNVD |
Malignant peripheral nerve sheath tumor | 18522746 | CNVD |
Gastrointestinal stromal cancer | 20877625 | CNVD |
Glioblastoma | 17090523 | CNVD |
Multiple myeloma | 16616336 | CNVD |
Lung cancer | 16773561 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Breast cancer | 21364760 | CNVD |
Melanoma | 20877625 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
Breast cancer | 22522925 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr12:60517800-60523600 | Weak transcription | Breast variant Human Mammary Epithelial Cells (vHMEC) | Breast |
2 | chr12:60531000-60531800 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
3 | chr12:60531200-60531800 | Enhancers | A549 | lung |
4 | chr12:60531200-60532000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
5 | chr12:60532000-60536800 | Weak transcription | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
6 | chr12:60533200-60533400 | Enhancers | Aorta | Aorta |
7 | chr12:60534400-60535000 | Enhancers | Small Intestine | intestine |
8 | chr12:60535000-60535400 | Enhancers | K562 | blood |
9 | chr12:60535400-60537000 | Weak transcription | K562 | blood |
10 | chr12:60536800-60540600 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Female | -- |
11 | chr12:60537000-60537200 | Enhancers | K562 | blood |
12 | chr12:60537000-60540000 | Enhancers | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
13 | chr12:60537200-60537600 | Weak transcription | K562 | blood |
14 | chr12:60537400-60538200 | Enhancers | Primary hematopoietic stem cells | blood |
15 | chr12:60537600-60537800 | Enhancers | K562 | blood |
16 | chr12:60537800-60538200 | Flanking Active TSS | K562 | blood |
17 | chr12:60538200-60538400 | Enhancers | K562 | blood |
18 | chr12:60538200-60539000 | Enhancers | Primary hematopoietic stem cells short term culture | blood |
19 | chr12:60538400-60538600 | Flanking Active TSS | K562 | blood |
20 | chr12:60538600-60538800 | Enhancers | K562 | blood |
21 | chr12:60538800-60540000 | Weak transcription | K562 | blood |
22 | chr12:60540000-60540400 | Flanking Active TSS | Primary hematopoietic stem cells G-CSF-mobilized Male | -- |
23 | chr12:60540000-60540600 | Enhancers | K562 | blood |
24 | chr12:60540000-60542800 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |